Site notifications

Sub menu

 

 

Ozempic (semaglutide) shortage collection

There is a worldwide shortage of this diabetes medicine. TGA alerts relate to the shortage in Australia.

Increased global demand for semaglutide products is impacting availability of Ozempic (semaglutide) in Australia. Alerts on the shortage of Trulicity (dulaglutide) and Mounjaro (tirzepatide) are also accessible from this collection.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Type

Topics

Audiences

Read current information and updates at:

The pharmaceutical company that supplies Ozempic, Novo Nordisk, has recently advised the TGA and the Ozempic Medicine Shortage Action Group that supply throughout 2025 will be limited.

Visit the Medicine shortage reports database to search for all medicines in shortage and find information about management actions.

10 result(s) found, displaying 1 to 10